IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Trading Halt, page-188

  1. 6,828 Posts.
    lightbulb Created with Sketch. 1729
    Fantastic news! - potential for IHL -675A to become a multi use medication. I think the market for this potential med has been expanded significantly with this new area of application. Key takeout for me is that we are seeing efficacy beyond respiratory conditions, so the probability of 675 A being a real "discovery" has gone up even further as well as an extended global market. This is one of the most significant Ann to date I think.

    IHL continues to forge ahead successfully with breakthrough R&D - great work by the team! Pity the sellers, you never know what is around the corner...
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.